T
COMPANY PROFILE
Toma Biosciences
Dna-based cancer testing technology the company was incorporated in 2011 and is based in
Valuation
$10–25M
Last recorded · 2018
Headcount
<100
Current team size
Total funding
$10–50M
Disclosed equity funding
At a glance
- Founded
- 2011
- Headquarters
- Foster City, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Keiretsu Forum
Series B and later7 investors entered at this stage
Prolog Ventures- SPSAYJ Global Partners
Correlation Ventures
Keiretsu Forum CEE
Keiretsu Capital
Paladin Capital Group
Vital Capital
Team profiled
8
named & role-tagged
Founders
Hidden — book a demo/100
quality score
Key operators
4
quality Hidden — book a demo/100
Potential founders
Hidden — book a demo
likely future founders
Startup mafia
Hidden — book a demo
alumni-founded startups
Talent movements
Hidden — book a demo in · Hidden — book a demo out
past 12 months
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Toma Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Toma Biosciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.